Form 4: Dianne M. Parrotte Reports Acquisition of Restricted Stock Units in Cognex Corp
SEC Form 4 Filing
Director Dianne M. Parrotte reports acquisition of restricted stock units in Cognex Corp, with vesting occurring on February 18, 2025.
Summary
- Dianne M. Parrotte, a director of Cognex Corp, filed a Form 4 indicating changes in beneficial ownership.
- The report details the acquisition of 8,324 restricted stock units (RSUs) on February 18, 2025, which vest 100% on the first anniversary of the grant date.
- Parrotte also holds various non-qualified stock options and other restricted stock units with different grant and expiration dates.
- Following the reported transaction, Parrotte directly owns 11,340 shares of common stock.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. The acquisition of RSUs by a director is generally a good sign, indicating confidence in the company's future. However, it's a routine transaction and doesn't necessarily indicate a major shift in the company's prospects.
Positives
- The acquisition of restricted stock units by a director signals confidence in the company's future performance.
Future Outlook
The report does not contain specific forward-looking statements, but the vesting of restricted stock units in the future suggests an expectation of continued employment and contribution to the company.
Industry Context
This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies. It provides transparency to investors regarding the holdings of company insiders.
Comparison to Industry Standards
- Stock option and RSU grants are a common form of executive compensation in the technology industry, used to align management's interests with those of shareholders.
- Companies like Keyence, Omron, and Teledyne Technologies also utilize similar equity-based compensation plans for their executives.
- The vesting schedules and exercise prices are generally in line with industry practices for companies of Cognex's size and market capitalization.
Stakeholder Impact
- The disclosure provides transparency to shareholders regarding the equity holdings of a key company director.
- Employees may view the RSU grants as a positive sign of the company's commitment to its leadership.
Key Dates
| Date | Description |
|---|---|
| 05/02/2019 | Grant date of non-qualified stock option with an exercise price of $45.06, expiring on 05/02/2028. |
| 02/19/2020 | Grant date of non-qualified stock option with an exercise price of $51.49, expiring on 02/19/2029. |
| 02/18/2021 | Grant date of non-qualified stock option with an exercise price of $50.94, expiring on 02/18/2030. |
| 02/22/2023 | Grant date of restricted stock units vesting on 02/22/2025. |
| 02/21/2024 | Grant date of restricted stock units vesting on 02/21/2026. |
| 02/18/2025 | Date of transaction: Acquisition of 8,324 restricted stock units. |
| 02/18/2026 | Vesting date for the 8,324 restricted stock units acquired on 02/18/2025. |
Keywords
Form 4, Cognex Corp, Director, Dianne M. Parrotte, Restricted Stock Units, Stock Options, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.